| Reducing population salt intake worldwide: from evidence to implementation. | |
| | |
MedLine Citation:
|
PMID: 20226955 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Raised blood pressure is a major cause of cardiovascular disease, responsible for 62% of stroke and 49% of coronary heart disease. There is overwhelming evidence that dietary salt is the major cause of raised blood pressure and that a reduction in salt intake lowers blood pressure, thereby, reducing blood pressure-related diseases. Several lines of evidence including ecological, population, and prospective cohort studies, as well as outcome trials, demonstrate that a reduction in salt intake is related to a lower risk of cardiovascular disease. Increasing evidence also suggests that a high salt intake may directly increase the risk of stroke, left ventricular hypertrophy, and renal disease; is associated with obesity through soft drink consumption; is related to renal stones and osteoporosis; is linked to the severity of asthma; and is probably a major cause of stomach cancer. In most developed countries, a reduction in salt intake can be achieved by a gradual and sustained reduction in the amount of salt added to foods by the food industry. In other countries where most of the salt consumed comes from salt added during cooking or from sauces, a public health campaign is needed to encourage consumers to use less salt. Several countries have already reduced salt intake. The challenge now is to spread this out to all other countries. A modest reduction in population salt intake worldwide will result in a major improvement in public health. |
| | |
Authors:
|
Feng J He; Graham A MacGregor |
Related Documents
:
|
6038695 - Barometric pressure fluctuations: effects on the activity of laboratory mice. 21519745 - The effects of agaricus sylvaticus fungi dietary supplementation on the metabolism and ... 8587445 - Blood pressure-independent inhibition by lacidipine of endothelin-1-related cardiac hyp... 7128025 - Inhibition of adrenaline-forming enzyme in the brain prevents one-kidney, one-clip hype... 20970305 - Systolic and diastolic myocardial mechanics in patients with cardiac disease and preser... 7233465 - In vivo and in vitro studies on the cerebrovascular dilatation induced by diazoxide in ... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Progress in cardiovascular diseases Volume: 52 ISSN: 1532-8643 ISO Abbreviation: Prog Cardiovasc Dis Publication Date: 2010 Mar-Apr |
Date Detail:
|
Created Date: 2010-03-15 Completed Date: 2010-04-01 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0376442 Medline TA: Prog Cardiovasc Dis Country: United States |
Other Details:
|
Languages: eng Pagination: 363-82 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright 2010 Elsevier Inc. All rights reserved. |
Affiliation:
|
Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK. f.he@qmul.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Blood Pressure Cardiovascular Diseases / economics, etiology, physiopathology, prevention & control* Cost-Benefit Analysis Diet, Sodium-Restricted* / economics Evidence-Based Medicine Food Industry Health Care Costs Health Promotion Humans Hypertension / economics, etiology, physiopathology, prevention & control* Nutrition Policy* Public Health Risk Assessment Risk Factors Risk Reduction Behavior Sodium Chloride, Dietary / adverse effects* World Health* |
| Chemical | |
Reg. No./Substance:
|
0/Sodium Chloride, Dietary |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Dogs and cats as environmental fall hazards.
Next Document: Congestion as a Therapeutic Target in Acute Heart Failure Syndromes.